Table 3.
The association between laboratory findings and neurological sequelae of ANE.
| Laboratory findings | Neurological sequelae | r | P-value | |||
|---|---|---|---|---|---|---|
| Mild (n = 8) | Moderate (n = 12) | Severe (n = 14) | ||||
| ALT | Normal | 5 (62.5%) | 6 (50%) | 3 (21.4%) | 0.345a | 0.045 |
| High | 3 (37.5%) | 6 (50%) | 11 (78.6%) | |||
| AST | Normal | 4 (50%) | 4 (33.3%) | 1 (7.1%) | 0.393a | 0.022 |
| High | 4 (50%) | 8 (66.7%) | 13 (92.9%) | |||
| CSF protein | Normal | 5 (62.5%) | 6 (50%) | 1 (7.1%) | 0.490a | 0.003 |
| High | 3 (37.5%) | 6 (50%) | 13 (92.9%) | |||
ALT, alanine aminotransferase; AST, aspartate transaminase; CSF, cerebrospinal fluid.
Use Spearman correlation test.